[HTML][HTML] Lenalidomide plus dexamethasone for high-risk smoldering multiple myeloma

MV Mateos, MT Hernández, P Giraldo… - … England Journal of …, 2013 - Mass Medical Soc
Background For patients with smoldering multiple myeloma, the standard of care is observation
until symptoms develop. However, this approach does not identify high-risk patients who …

Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: results of a multicenter phase 1/2 study

MV Mateos, JM Hernández, MT Hernández… - Blood, 2006 - ashpublications.org
Standard first-line treatment for elderly multiple myeloma (MM) patients ineligible for stem
cell transplantation is melphalan plus prednisone (MP). However, complete responses (CRs) …

Vitamin D status in hospitalized patients with SARS-CoV-2 infection

…, MA Hernández-Hernández… - The Journal of …, 2021 - academic.oup.com
Background The role of vitamin D status in COVID-19 patients is a matter of debate.
Objectives To assess serum 25-hydroxyvitamin D (25OHD) levels in hospitalized patients with …

Depth of response in multiple myeloma: a pooled analysis of three PETHEMA/GEM clinical trials

…, R de Paz, F de Arriba, MT Hernandez… - Journal of Clinical …, 2017 - ascopubs.org
Purpose To perform a critical analysis on the impact of depth of response in newly diagnosed
multiple myeloma (MM). Patients and Methods Data were analyzed from 609 patients who …

A family of Chebyshev-Halley type methods in Banach spaces

JM Gutierrez, MA Hernández - Bulletin of the Australian …, 1997 - cambridge.org
A family of third-order iterative processes (that includes Chebyshev and Halley's methods)
is studied in Banach spaces. Results on convergence and uniqueness of solution are given, …

Bisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytochrome P450 CYP2C8 in multiple myeloma: a genome-wide single …

…, J De la Rubia, MT Hernandez… - Blood, The Journal …, 2008 - ashpublications.org
We have explored the potential role of genetics in the development of osteonecrosis of the
jaw (ONJ) in multiple myeloma (MM) patients under bisphosphonate therapy. A genome-wide …

Measurable residual disease by next-generation flow cytometry in multiple myeloma

…, A Sureda, MT Hernandez… - Journal of Clinical …, 2020 - ascopubs.org
PURPOSE Assessing measurable residual disease (MRD) has become standard with many
tumors, but the clinical meaning of MRD in multiple myeloma (MM) remains uncertain, …

In situ radiometric and exposure age dating of the Martian surface

…, K Herkenhoff, EM Lee, R Sucharski, MÁP Hernández… - science, 2014 - science.org
We determined radiogenic and cosmogenic noble gases in a mudstone on the floor of Gale
Crater. A K-Ar age of 4.21 ± 0.35 billion years represents a mixture of detrital and authigenic …

Lenalidomide plus dexamethasone versus observation in patients with high-risk smouldering multiple myeloma (QuiRedex): long-term follow-up of a randomised …

MV Mateos, MT Hernández, P Giraldo… - The lancet …, 2016 - thelancet.com
Background The standard of care for smouldering multiple myeloma is observation. We did
the QuiRedex study to compare early treatment with lenalidomide plus dexamethasone with …

Minimal residual disease monitoring and immune profiling in multiple myeloma in elderly patients

…, EM Ocio, MT Hernandez… - Blood, The Journal …, 2016 - ashpublications.org
The value of minimal residual disease (MRD) in multiple myeloma (MM) has been more
frequently investigated in transplant-eligible patients than in elderly patients. Because an …